| Symbol | COAG |
|---|---|
| Name | HEMAB THERAPEUTICS HOLDINGS, INC. |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Biological Products, (No Diagnostic Substances) |
| Address | 101 MAIN STREET, CAMBRIDGE, MA 02142 |
| Telephone | 45 2138 7627 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0002114044 |
| Description | None |
New Form SCHEDULE 13G - Hemab Therapeutics Holdings, Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001388325-26-000046 <b>Size:</b> 6 KB
Read moreThe Galien Foundation Announces 2026 Prix Galien USA Nominees for "Best Digital Health Solution," "Best Medical Technology," "Incubators, Accelerators and Equity," and "Best Startup"
Read moreNew Form SCHEDULE 13G - Hemab Therapeutics Holdings, Inc. <b>Filed:</b> 2026-08-12 <b>AccNo:</b> 0001562230-26-000124 <b>Size:</b> 7 KB
Read more(30% Negative) HEMAB THERAPEUTICS HOLDINGS, INC. (COAG) Reports Q3 2026 Financial Results
Read moreNew Form SCHEDULE 13G - Hemab Therapeutics Holdings, Inc. <b>Filed:</b> 2026-08-07 <b>AccNo:</b> 0002005369-26-000041 <b>Size:</b> 25 KB
Read moreHemab Therapeutics Presents New Clinical Data from HMB-002 in Von Willebrand Disease and Introduces HMB-003 for Heavy Menstrual Bleeding at the ISTH 2026 Congress
Read moreHemab Therapeutics to Present Clinical and Preclinical Data from Multiple Blood Coagulation Programs at the ISTH 2026 Congress
Read moreRA CAPITAL MANAGEMENT, L.P. 🟢 acquired 67.7K shares of Hemab Therapeutics Holdings, Inc. (COAG) at $24.98 ($1.7M) Transaction Date: Jun 15, 2026 | Filing ID: 000665
Read more(30% Negative) HEMAB THERAPEUTICS HOLDINGS, INC. (COAG) Reports Q2 2026 Financial Results
Read more